Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA3W6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,979
Award facts
- Contract value 100% obligated
- $47,979.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,979.41 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This firm fixed-price, non-set-aside contract was awarded on January 27, 2026, with an ultimate completion date of January 28, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract (IDC) mechanism with DLA Troop Support Medical.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities, the Defense Health Agency, and veteran healthcare programs. The company holds a primary IDC with DLA Troop Support Medical valued at up to $999.9 million through December 2026, which provides a comprehensive vehicle for delivering a wide range of pharmaceutical products, specialty medications, and medical supplies to support global military healthcare operations. The award of this specific diabetes medication delivery order demonstrates the company's role in supplying prescription medications across multiple therapeutic domains to federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FA3W6?
SPE2DR26FA3W6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FA3W6 worth?
The government has obligated $47,979 on SPE2DR26FA3W6.
Is contract SPE2DR26FA3W6 an order under another contract?
Yes. SPE2DR26FA3W6 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3W6 competed?
The extent of competition for SPE2DR26FA3W6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award